Back to BCRX
Cambridge Investment Research Advisors, Inc. → BCRX
Cambridge Investment Research Advisors, Inc. BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$107K
Q3 2026
Peak value
$223K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $170K |
| Q4 2025 | $152K |
| Q1 2026 | $223K |
| Q2 2026 | $199K |
| Q2 2026 | $199K |
| Q3 2026 | $107K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $107K | 12.8K | — | — |
| Q2 2026 | $199K | 19.9K | — | — |
| Q2 2026 | $199K | 19.9K | — | — |
| Q1 2026 | $223K | 23.4K | — | — |
| Q4 2025 | $152K | 19.5K | — | — |
| Q3 2025 | $170K | 22.4K | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$152.7M
$151.9M
$151.9M
$116.2M